R. Tsutsumi

发表

Control of calcium oscillations by phosphorylation of metabotropic glutamate receptors

Shigetada Nakanishi, S. Nakanishi, Tokio Yamaguchi, 1996, Nature.

L-365,260, a potent CCK-B/gastrin receptor antagonist, suppresses gastric acid secretion induced by histamine and bethanechol as well as pentagastrin in rats.

A. Nishida, K. Honda, K. Miyata, 1992, Japanese journal of pharmacology.

Comparative study of the affinities of the 5-HT3 receptor antagonists, YM060, YM114 (KAE-393), granisetron and ondansetron in rat vagus nerve and cerebral cortex

A. Nishida, S. Akuzawa, K. Miyata, 1995, Neuropharmacology.

Celecoxib inhibits production of MMP and NO via down-regulation of NF-κB and JNK in a PGE2 independent manner in human articular chondrocytes

H. Ito, K. Nishitani, T. Nakamura, 2008, Rheumatology International.

Inhibiteurs de neurocytotoxicite de l'acide kainique

H. Yamashita, R. Tsutsumi, H. Kaku, 2000 .

Pharmacological profile of (R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo- 5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivo.

A. Nishida, S. Akuzawa, K. Miyata, 1994, The Journal of pharmacology and experimental therapeutics.

Role of the serotonin3 receptor in stress-induced defecation.

A. Nishida, K. Honda, K. Miyata, 1992, The Journal of pharmacology and experimental therapeutics.

Serotonin (5-HT)3 receptor blocking activities of YM060, a novel 4,5,6,7-tetrahydrobenzimidazole derivative, and its enantiomer in anesthetized rats.

A. Nishida, K. Miyata, R. Tsutsumi, 1991, The Journal of pharmacology and experimental therapeutics.

Pharmacologic profile of (R)-5-[(1-methyl-3-indolyl)carbonyl]-4,5,6,7-tetrahydro-1H- benzimidazole hydrochloride (YM060), a potent and selective 5-hydroxytryptamine3 receptor antagonist, and its enantiomer in the isolated tissue.

A. Nishida, K. Miyata, R. Tsutsumi, 1991, The Journal of pharmacology and experimental therapeutics.

Serotonin (5-HT)3-receptor antagonism of 4,5,6,7-tetrahydrobenzimidazole derivatives against 5-HT-induced bradycardia in anesthetized rats.

A. Nishida, K. Honda, K. Miyata, 1994, Japanese journal of pharmacology.

In‐vitro Characterization of YM872, a Selective, Potent and Highly Water‐soluble α‐Amino‐3‐hydroxy‐5‐methylisoxazole‐4‐propionate Receptor Antagonist

R. Tsutsumi, A. Kohara, Tokio Yamaguchi, 1998, The Journal of pharmacy and pharmacology.

Diversity of Calcium Signaling by Metabotropic Glutamate Receptors*

H. Itahana, S. Kawabata, R. Tsutsumi, 1998, The Journal of Biological Chemistry.

Kainate excitotoxicity is mediated by AMPA- but not kainate-preferring receptors in embryonic rat hippocampal cultures

R. Tsutsumi, A. Kohara, Tokio Yamaguchi, 1997, Neurochemistry International.

Characterization of cyclothiazide-enhanced kainate excitotoxicity in rat hippocampal cultures

N. Matsumoto, R. Tsutsumi, Tokio Yamaguchi, 1998, Neurochemistry International.

Functional Characterization of YM928, a Novel Noncompetitive α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Antagonist

H. Yamashita, N. Matsumoto, R. Tsutsumi, 2003, Journal of Pharmacology and Experimental Therapeutics.

Functional Characterization of YM928, a Novel Noncompetitive AMPA Receptor Antagonist

N. Matsumoto, R. Tsutsumi, M. Okada, 2003 .

The AMPA-receptor antagonist YM90K reduces AMPA receptor-mediated excitotoxicity in rat hippocampal cultures.

R. Tsutsumi, M. Okada, S. Sakamoto, 1998, Japanese journal of pharmacology.